Conventional fractionation should not be the standard of care for T2 glottic cancer

BACKGROUND: The aim of this study was to report outcomes and late toxicity following hypofractionated accelerated radiotherapy for T2 glottic cancers. We highlight the importance of hypofractionated treatments with shorter overall treatment times, in improving outcomes for T2 glottic cancers. We als...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, Lynne M., Douglas, Catriona M., Shaukat, Shazril Imran, Garcez, Kate, Lee, Lip Wai, Sykes, Andrew J., Thomson, David, Slevin, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686811/
https://www.ncbi.nlm.nih.gov/pubmed/29137654
http://dx.doi.org/10.1186/s13014-017-0915-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686811/
https://www.ncbi.nlm.nih.gov/pubmed/29137654
http://dx.doi.org/10.1186/s13014-017-0915-8

Ejemplares similares